AMY M. STURMER,KIM HENRIKSEN,MORTEN ASSER KARSDAL,NOZER M. MEHTA,WILLIAM STERN,KIM HENDRIKSEN
申请号：
BR112014010701
公开号：
BR112014010701A2
申请日:
2012.11.02
申请国别(地区):
BR
年份:
2020
代理人:
摘要：
A peptide having a sequence selected from SEQ ID NO:11, SEQ ID NO:12, SEQ ID NO:13, SEQ ID NO:14, SEQ ID NO:15, SEQ ID NO:16, SEQ ID NO:17 and SEQ ID NO:18. Said peptide used for the treatment of type I diabetes, Type II diabetes, metabolic syndrome, or obesity, or of apetite suppression, or for mitigating insulin resistance, or for reducing an undesirably high fasting serum glucose level, or for reducing an undesirably high peak serum glucose level, or for reducing an undesirably high peak serum insulin level, or for reducing an undesirably large response to a glucose tolerance test.
